BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 26403224)

  • 1. HMGA2 as a potential molecular target in KMT2A-AFF1-positive infant acute lymphoblastic leukaemia.
    Wu Z; Eguchi-Ishimae M; Yagi C; Iwabuki H; Gao W; Tauchi H; Inukai T; Sugita K; Ishii E; Eguchi M
    Br J Haematol; 2015 Dec; 171(5):818-29. PubMed ID: 26403224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy.
    Cheung LC; Aya-Bonilla C; Cruickshank MN; Chiu SK; Kuek V; Anderson D; Chua GA; Singh S; Oommen J; Ferrari E; Hughes AM; Ford J; Kunold E; Hesselman MC; Post F; Faulk KE; Breese EH; Guest EM; Brown PA; Loh ML; Lock RB; Kees UR; Jafari R; Malinge S; Kotecha RS
    Leukemia; 2023 Jan; 37(1):61-71. PubMed ID: 36380143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infant Acute Lymphoblastic Leukemia-New Therapeutic Opportunities.
    Kulczycka M; Derlatka K; Tasior J; Sygacz M; Lejman M; Zawitkowska J
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KMT2A oncoproteins induce epigenetic resistance to targeted therapies.
    Janssens DH; Duran M; Otto DJ; Kirkey D; Yi JS; Meshinchi S; Sarthy JF; Ahmad K; Henikoff S
    bioRxiv; 2023 Dec; ():. PubMed ID: 38234854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Menin story in acute myeloid leukaemia-The road to success.
    Kühn MWM; Ganser A
    Br J Haematol; 2024 May; ():. PubMed ID: 38710595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proximally biased V(D)J recombination in the clonal evolution of IGH alleles in
    Müller H; Dicker F; Bär C; Walter W; Hutter S; Nadarajah N; Meggendorfer M; Gao Q; Iacobucci I; Mullighan CG; Kern W; Haferlach T; Haferlach C
    Hemasphere; 2024 Apr; 8(4):e71. PubMed ID: 38650597
    [No Abstract]   [Full Text] [Related]  

  • 7. A CD10-negative adult B-lymphoblastic leukaemia with amplification of KMT2A without rearrangement: A case report and review of the English literature.
    Wang HY; Louis HMS; Costello CL; Murray SS; Dell'Aquila ML
    Br J Haematol; 2024 May; ():. PubMed ID: 38735761
    [No Abstract]   [Full Text] [Related]  

  • 8. The KMT2A/MLL consensus gene structure: a comprehensive update for research and diagnostic implications.
    Meyer C; Larghero P; Lopes BA; Marschalek R
    Leukemia; 2024 Apr; ():. PubMed ID: 38678092
    [No Abstract]   [Full Text] [Related]  

  • 9. Hematopoietic Differentiation Is Required for Initiation of Acute Myeloid Leukemia.
    Ye M; Zhang H; Yang H; Koche R; Staber PB; Cusan M; Levantini E; Welner RS; Bach CS; Zhang J; Krivtsov AV; Armstrong SA; Tenen DG
    Cell Stem Cell; 2015 Nov; 17(5):611-23. PubMed ID: 26412561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia.
    Sanjuan-Pla A; Bueno C; Prieto C; Acha P; Stam RW; Marschalek R; Menéndez P
    Blood; 2015 Dec; 126(25):2676-85. PubMed ID: 26463423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant stem cell and developmental programs in pediatric leukemia.
    Ling RE; Cross JW; Roy A
    Front Cell Dev Biol; 2024; 12():1372899. PubMed ID: 38601080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of Natural Compounds with HMGA-Interfering Activities and Cancer Cell Cytotoxicity.
    Mori M; Ghirga F; Amato B; Secco L; Quaglio D; Romeo I; Gambirasi M; Bergamo A; Covaceuszach S; Sgarra R; Botta B; Manfioletti G
    ACS Omega; 2023 Sep; 8(36):32424-32431. PubMed ID: 37720761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and the Diagnosis of Childhood Acute Lymphoblastic Leukemia: Systematic Review, Meta-Analysis and Re-Analysis with Novel Small RNA-Seq Tools.
    Kyriakidis I; Kyriakidis K; Tsezou A
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative multi-omics and drug response profiling of childhood acute lymphoblastic leukemia cell lines.
    Leo IR; Aswad L; Stahl M; Kunold E; Post F; Erkers T; Struyf N; Mermelekas G; Joshi RN; Gracia-Villacampa E; Östling P; Kallioniemi OP; Tamm KP; Siavelis I; Lehtiö J; Vesterlund M; Jafari R
    Nat Commun; 2022 Mar; 13(1):1691. PubMed ID: 35354797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of PLAG1, HMGA1 and HMGA2 in minor salivary glands tumours.
    Barca I; Mignogna C; Donato G; Cristofaro MG
    Gland Surg; 2021 May; 10(5):1609-1617. PubMed ID: 34164305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGA Proteins in Hematological Malignancies.
    Minervini A; Coccaro N; Anelli L; Zagaria A; Specchia G; Albano F
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32503270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of hub genes and molecular mechanisms in infant acute lymphoblastic leukemia with
    Zhang H; Cheng J; Li Z; Xi Y
    PeerJ; 2019; 7():e7628. PubMed ID: 31523525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fetal liver lymphoid-primed multipotent progenitor provides the prerequisites for the initiation of t(4;11)
    Malouf C; Ottersbach K
    Haematologica; 2018 Dec; 103(12):e571-e574. PubMed ID: 29903765
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrative Analysis of Proteome and Ubiquitylome Reveals Unique Features of Lysosomal and Endocytic Pathways in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells.
    Li W; Wang H; Yang Y; Zhao T; Zhang Z; Tian Y; Shi Z; Peng X; Li F; Feng Y; Zhang L; Jiang G; Zhang F
    Proteomics; 2018 Aug; 18(15):e1700388. PubMed ID: 29901268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular processes involved in B cell acute lymphoblastic leukaemia.
    Malouf C; Ottersbach K
    Cell Mol Life Sci; 2018 Feb; 75(3):417-446. PubMed ID: 28819864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.